Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK3486 vs propofol for induction of general anesthesia in adults undergoing elective surgery
2023-507009-32-00Phase 3Completed
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Feb 2024
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial of ciprofol in general anesthesia (2 arms), sponsored by Haisco Pharmaceutical Group Co., Ltd. Primary endpoint: Success rate of general anesthesia induction. Started Feb 2024; status: completed.
02
Drugs
ciprofol
03
Conditions
general anesthesia
Beyond the preview
Go deeper on 2023-507009-32-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507009-32-00.